XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
XORTX Therapeutics Inc. has appointed Dr. Michael Bumby as the new Chief Financial Officer, bringing his extensive experience in finance and leadership within the biotech and pharma industries. The appointment is expected to provide strategic financial guidance to the company as it advances its clinical development programs.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.